IOVA
Iovance Biotherapeutics, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +1.4% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q4 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 103 | +5 | 196.52M | $817.32M | +8 | −3 |
| Q1 2026 | 101 | +2 | 181.45M | $636.15M | +8 | −6 |
| Q4 2025 | 98 | +1 | 178.19M | $486.45M | +1 | — |
| Q3 2025 | 14 | -2 | 98.05M | $212.78M | — | −2 |
| Q2 2025 | 13 | -2 | 89.90M | $154.64M | — | −2 |
| Q1 2025 | 12 | +2 | 25.73M | $85.68M | +2 | — |
| Q4 2024 | 10 | 0 | 23.63M | $174.86M | +2 | −2 |
| Q3 2024 | 9 | -1 | 11.04M | $103.72M | +1 | −2 |
| Q2 2024 | 10 | — | 13.79M | $110.63M | — | — |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (passief) | 12.25M | — | $90.64M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passief) | 5.87M | +3.9% | $43.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 5.87M | +3.9% | $43.46M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 2.63M | -15.3% | $19.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 2.63M | -15.3% | $19.45M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 6 | Marshall Wace ✦ | 1.13M | Nieuw | $8.37M | 0.0% | New | 1 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.13M | Nieuw | $8.37M | 0.0% | New | 1 | SEC ↗ |
| 8 | Marshall Wace ✦ | 1.13M | Nieuw | $8.37M | 0.0% | New | 1 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 1.09M | +6.8% | $8.09M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Norges Bank ✦ (passief) | 416.24K | -45.7% | $3.08M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 117.43K | -9.3% | $868,952 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 117.43K | -9.3% | $868,952 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 117.43K | -9.3% | $868,952 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 117.43K | -9.3% | $868,952 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 15 | Millennium Management ✦ | 75.49K | -50.0% | $558,656 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 16 | D. E. Shaw & Co. ✦ | 30.81K | -54.5% | $228,009 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 15.71K | Nieuw | $114,061 | 0.0% | New | 1 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 15.71K | Nieuw | $114,061 | 0.0% | New | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $8.37M | 0.0% |
| Marshall Wace | $8.37M | 0.0% |
| Marshall Wace | $8.37M | 0.0% |
| AQR Capital Management | $114,061 | 0.0% |
| AQR Capital Management | $114,061 | 0.0% |
Verlaten
| Two Sigma Investments | $867,336 | was 0.0% |
| Gotham Asset Management | $572,875 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 282 houders, 266.49M aandelen, $901.79M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.